Ardent Health, Inc. (ARDT) dropped 33.02% to $9.41, down $4.64, after reporting its third quarter 2025 results.
The company posted $1.58 billion in revenue, up 8.8 percent year-over-year, and $143 million in adjusted EBITDA, a 46.3 percent increase.
Despite the top-line growth and margin expansion, Ardent cut its full-year adjusted EBITDA guidance to $530-$555 million, down from the previous $575-$615 million, citing accelerating professional fee expense growth and an uptick in payor denials.
On the day of the announcement, ARDT experienced unusually heavy trading volume as investors reacted to the muted outlook. The stock's 52-week range is $9.00 - $15.00.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.